Statistics
Publications
2
Citations
94
H-Index
2
Active since
2021
Affiliations
Yinfeng Gu is an author at Affiliated Hospital of Nantong University specializing in oncology, cancer transcriptomics, and programmed cell death protein 1 (pd-1) pathway.
Publications per year
2021–2024
2
2
CD69 is a Promising Immunotherapy and Prognosis Prediction Target in Cancer
Yuchen Li, Yinfeng Gu, Pengyue Yang et al. · ImmunoTargets and Therapy · 2024 · 47 citations · Full text
Life Sciences, Immunology, Oncology +17
1–2 of 2